Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Novel treatments for male erectile dysfunction

May 17, 2002

Rho kinase as a potential target for erectile dysfunction Rx

May 17, 2002

CYC-202 to be evaluated in glomerulonephritis

May 16, 2002

Data support inhibition of hypocretin system in the treatment of urinary incontinence

May 16, 2002

Phase II trials begin in Europe and U.S. for KW-7158

May 16, 2002

Tadalafil: a new treatment option for men with erectile dysfunction

May 14, 2002

Tadalafil, an important new treatment option for most men with ED

May 13, 2002

Alpha1-adrenoceptor antagonists useful for urological disorders

May 10, 2002

YC-1 may be useful for treating erectile dysfunction

May 10, 2002

Positive pharmacokinetic results for buccal desmopressin

May 10, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...